Recent studies fueled doubts as to whether all currently defined central disorders of hypersomnolence are stable entities, especially narcolepsy type 2 and idiopathic hypersomnia. New reliable biomarkers are needed, and the question arises of whether current diagnostic criteria of hypersomnolence disorders should be reassessed. The main aim of this data-driven observational study was to see whether data-driven algorithms would segregate narcolepsy type 1 and identify more reliable subgrouping of individuals without cataplexy with new clinical biomarkers. We used agglomerative hierarchical clustering, an unsupervised machine learning algorithm, to identify distinct hypersomnolence clusters in the large-scale European Narcolepsy Network datab...
The classification of the central disorders of hypersomnolence has undergone multiple iterations in ...
Narcolepsy type 1 (NT1) is a disorder with well-established markers and a suspected autoimmune aetio...
The classification of the central disorders of hypersomnolence has undergone multiple iterations in ...
Background and ObjectivesRecent studies fueled doubts as to whether all currently defined central di...
BACKGROUND AND OBJECTIVES Recent studies fueled doubts as to whether all currently defined centra...
The aim of this European initiative is to facilitate a structured discussion to improve the next edi...
Summary The aim of this European initiative is to facilitate a structured discussion to improve the ...
Narcolepsy is a rare life-long disease that exists in two forms, narcolepsy type-1 (NT1) or type-2 (...
The aim of this European initiative is to facilitate a structured discussion to improve the next edi...
The classification of the central disorders of hypersomnolence has undergone multiple iterations in ...
Narcolepsy type 1 (NT1) is a disorder with well-established markers and a suspected autoimmune aetio...
The classification of the central disorders of hypersomnolence has undergone multiple iterations in ...
Background and ObjectivesRecent studies fueled doubts as to whether all currently defined central di...
BACKGROUND AND OBJECTIVES Recent studies fueled doubts as to whether all currently defined centra...
The aim of this European initiative is to facilitate a structured discussion to improve the next edi...
Summary The aim of this European initiative is to facilitate a structured discussion to improve the ...
Narcolepsy is a rare life-long disease that exists in two forms, narcolepsy type-1 (NT1) or type-2 (...
The aim of this European initiative is to facilitate a structured discussion to improve the next edi...
The classification of the central disorders of hypersomnolence has undergone multiple iterations in ...
Narcolepsy type 1 (NT1) is a disorder with well-established markers and a suspected autoimmune aetio...
The classification of the central disorders of hypersomnolence has undergone multiple iterations in ...